Advancing Plasmodium vivax vaccines: A novel multistage antigen meets mRNA technology

According to the WHO World Malaria Report 2025, Plasmodium vivax malaria accounts for approximately 10 million symptomatic cases annually.1 Although less lethal than Plasmodium falciparum, acute P. vivax infection may cause a cytokine storm, severe disease and death,2 particularly among vulnerable populations and remains a major public health problem in Asia, Latin America, and parts of Africa. Furthermore, the high prevalence of silent asymptomatic cases that remain untreated, undermines the measures to control disease transmission,3 which are primarily based on treatment of symptomatic cases and use of insecticide for vector elimination.

Authors

Institutions

Publication Details

Journal
Molecular Therapy — Nucleic Acids
Published
2026-11-18
DOI
https://doi.org/10.1016/j.omtn.2026.103176
Primary Topic
Malaria Research and Control
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Advancing Plasmodium vivax vaccines: A novel multistage antigen meets mRNA technology

Denis Alexis Molina Molina, Ricardo T. Gazzinelli
Molecular Therapy — Nucleic Acids
Malaria Research and Control
article

Advancing Plasmodium vivax vaccines: A novel multistage antigen meets mRNA technology

Denis Alexis Molina Molina, Ricardo T. Gazzinelli
article en

Abstract

According to the WHO World Malaria Report 2025, Plasmodium vivax malaria accounts for approximately 10 million symptomatic cases annually.1 Although less lethal than Plasmodium falciparum, acute P. vivax infection may cause a cytokine storm, severe disease and death,2 particularly among vulnerable populations and remains a major public health problem in Asia, Latin America, and parts of Africa. Furthermore, the high prevalence of silent asymptomatic cases that remain untreated, undermines the measures to control disease transmission,3 which are primarily based on treatment of symptomatic cases and use of insecticide for vector elimination.

Molecular Therapy — Nucleic AcidsVol. 37(4)
Universidade Federal de Minas Gerais (BR), Fiocruz Minas (BR), Fundação Oswaldo Cruz (BR)
Good health and well-being
Malaria Research and Control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon